This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
8 Jul 2024

KOLINPHARMA®: has achieved the first patent for Xinprox®

KOLINPHARMA®: has achieved the first patent for Xinprox®

XINPROX®, studied and developed for the well–being of the prostate, is a food supplement that includes in the formulation raw materials of high quality, technologically advanced, and supported by scientific studies, such as pollen extract, quercetin, alpha lipoic acid, and L-tryptophan.

Now, Kolinpharma has 46 patents in total, 7 in Italy, 6 in USA, 1 in Israel, and 32 in the principal States of UE.

Rita Paola Petrelli, president of Kolinpharma has commented: “We are proud to announce that we have achieved the first patent for Xinprox® which testifies the validity of the formulations and the work of the R&D department and of the all company. […] The research is one of our elements of strengths and for this reason, we want to continue and invest and value our product to offer to costumer–patient scientifically validated solutions, patent is synonymous with synergy, uniqueness, and innovation".

 

 
 

XINPROX®, studied and developed for the well–being of the prostate, is a food supplement that includes in the formulation raw materials of high quality, technologically advanced, and supported by scientific studies, such as pollen extract, quercetin, alpha lipoic acid, and L-tryptophan.

Now, Kolinpharma has 46 patents in total, 7 in Italy, 6 in USA, 1 in Israel, and 32 in the principal States of UE.

Rita Paola Petrelli, president of Kolinpharma has commented: “We are proud to announce that we have achieved the first patent for Xinprox® which testifies the validity of the formulations and the work of the R&D department and of the all company. […] The research is one of our elements of strengths and for this reason, we want to continue and invest and value our product to offer to costumer–patient scientifically validated solutions, patent is synonymous with synergy, uniqueness, and innovation".

 

 
 

Mentioned Companies
Kolinpharma
View company profile